Repository logo
 
Publication

Adherens Junction Integrity Is a Critical Determinant of Sodium Iodide Symporter Residency at the Plasma Membrane of Thyroid Cells

dc.contributor.authorFaria, Márcia
dc.contributor.authorVareda, José
dc.contributor.authorMiranda, Micaella
dc.contributor.authorBugalho, Maria João
dc.contributor.authorSilva, Ana Luísa
dc.contributor.authorMatos, Paulo
dc.date.accessioned2023-01-10T14:11:41Z
dc.date.available2023-01-10T14:11:41Z
dc.date.issued2022-10-31
dc.descriptionThis article belongs to the Special Issue Thyroid Carcinomapt_PT
dc.description.abstractWhile most cases of differentiated thyroid carcinoma (DTC) are associated with a good prognosis, a significant number progress to advanced disease exhibiting aggressive clinical characteristics and often becoming refractory to radioactive iodine (RAI) treatment, the current gold-standard therapeutic option for metastatic disease. RAI-refractoriness is caused by defective functional expression of the sodium-iodide symporter (NIS), which is responsible for the active transport of iodide across the plasma membrane (PM) into thyroid follicles. NIS deficiency in these tumors often reflects a transcriptional impairment, but also its defective targeting and retention at the cells’ PM. Using proteomics, we previously characterized an intracellular signaling pathway derived from SRC kinase that acts through the small GTPase RAC1 to recruit and bind the actin-anchoring adaptor EZRIN to NIS, regulating its retention at the PM of both non-transformed and cancer thyroid cells. Here, we describe how by reanalyzing the proteomics data, we identified cell–cell adhesion as the molecular event upstream the pathway involved in the anchoring and retention at the PM. We show that by interacting with NIS at the PM, adherens junction (AJ)-associated P120-catenin recruits and is phosphorylated by SRC, allowing it to recruit RAC1 to the complex. This enables SRC-phosphorylated VAV2 exchange factor to activate RAC1 GTPase, inducing NIS retention at the PM, thus increasing its abundance and function at the surface of thyroid cells. Our findings indicate that the loss of epithelial cell–cell adhesion may contribute to RAI refractoriness, indicating that in addition to stimulating NIS expression, successful resensitization therapies might require the employment of agents that improve cell–cell adhesion and NIS PM retention in refractory TC cells.pt_PT
dc.description.sponsorshipThis work was funded by Bolsa Edward Limbert Merck/SPEDM-2021 (grant Limbert2021 from Merck/SPEDM, Portugal) and Fundação para a Ciência e a Tecnologia (FCT), Portugal, through grants PTDC/BIAMOL/31787/2017 (to ALS and PM) and UID/MULTI/04046/2019 (to BioISI). MF was the recippt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationCancers (Basel). 2022 Oct 31;14(21):5362. doi: 10.3390/cancers14215362pt_PT
dc.identifier.doi10.3390/cancers14215362pt_PT
dc.identifier.issn2072-6694
dc.identifier.urihttp://hdl.handle.net/10400.18/8413
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherMDPIpt_PT
dc.relationSodium-iodide symporter posttranslational interactome: identification of novel targets to enhance iodide-related cancer therapy
dc.relationBiosystems & Integrative Sciences Institute
dc.relation.publisherversionhttps://www.mdpi.com/2072-6694/14/21/5362pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectThyroid Carcinomapt_PT
dc.subjectThyroid Cancerpt_PT
dc.subjectRAI-refractorypt_PT
dc.subjectNISpt_PT
dc.subjectAdherens Junctionspt_PT
dc.subjectPlasma Membrane Localizationpt_PT
dc.subjectVias de Transdução de Sinal e Patologias Associadaspt_PT
dc.titleAdherens Junction Integrity Is a Critical Determinant of Sodium Iodide Symporter Residency at the Plasma Membrane of Thyroid Cellspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleSodium-iodide symporter posttranslational interactome: identification of novel targets to enhance iodide-related cancer therapy
oaire.awardTitleBiosystems & Integrative Sciences Institute
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FBIA-MOL%2F31787%2F2017/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FMulti%2F04046%2F2019/PT
oaire.citation.issue21pt_PT
oaire.citation.startPage5362pt_PT
oaire.citation.titleCancerspt_PT
oaire.citation.volume14pt_PT
oaire.fundingStream3599-PPCDT
oaire.fundingStream6817 - DCRRNI ID
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.embargofctAcesso de acordo com política editorial da revista.pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isProjectOfPublication21f29b04-5f25-4fca-89e1-3ebf685647df
relation.isProjectOfPublication35168786-8dfc-4a00-9759-dab3669fe1ae
relation.isProjectOfPublication.latestForDiscovery21f29b04-5f25-4fca-89e1-3ebf685647df

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Faria et al_2022_cancers-14-05362.pdf
Size:
2.6 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: